The screening tests of hemostasis were developed to help identify patients with hemostatic defects that could cause excessive bleeding. Screening tests are available for each of the three phases of hemostasis: coagulation (fibrin clot formation), platelet plug formation, and fibrinolysis.
This new 302-page report provides an analysis of the global coagulation testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.
The report presents
Estimated numbers of coagulation testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S.
Clinical significance and market needs for major coagulation laboratory tests, as well as listings of companies developing or marketing new coagulation technologies and products.
Current instrumentation technologies and features of leading automated and semiautomated analyzers.
Assessments of chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for coagulation testing.
Profiles of current and emerging suppliers of coagulation testing products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Market Segmentation
Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Dot Immunobinding Assays
Capillary Immunoassays
Enzyme Amplification
Electrochemical Immunoassay
Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
Fluorescence Lifetime
Amplification Methods
PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
NASBA
Key Players
Abbott
ADI/American Diagnostica
Alere/Biosite/Inverness
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Siemens
Sienco
Sysmex
Thermo Fisher
ZyCare/Alere
Contact Details:
Aarkstore Enterprise
+917710006788 | [email protected] | www.aarkstore.com
